Certified by Founder
Lodge
KROMATID®
start up
United States
- Longmont, Colorado
- 21/08/2025
- Series C
- $8,000,000
Revolutionizing gene editing analysis for precision medicine and cutting-edge research.
For cell and gene therapy researchers, biotech and pharma companies, and regulatory professionals, KROMATID’s KROMASURE Platform is the genomic characterization solution that provides high-confidence, single-cell insights into chromosomal integrity, structural variants, and transgene mapping.
Unlike traditional sequencing methods, our technology directly visualizes up to thousands of single cells at a time, offering scalable, actionable data with unprecedented clarity, helping you confidently advance research and meet FDA regulatory requirements.
Visit our website to learn how we can support your research.
- Industry Biotechnology Research
- Website https://kromatid.com/
- LinkedIn https://www.linkedin.com/company/kromatid/
dazzle ai | $8,000,000 | (Jan 7, 2026)
Tesoro XP, Inc. | $5,400,000 | (Jan 7, 2026)
Lemon Slice | $10,500,000 | (Jan 7, 2026)
Array Labs | $20,000,000 | (Jan 7, 2026)
Lyte | $107,000,000 | (Jan 7, 2026)
Lucidean | $18,000,000 | (Jan 7, 2026)
CHAMP | $55,000,000 | (Jan 7, 2026)
Truemed | $34,000,000 | (Jan 7, 2026)
Coinbax | $4,200,000 | (Jan 7, 2026)
Peripheral Labs | $3,600,000 | (Dec 23, 2025)
Ciphero | $2,500,000 | (Dec 23, 2025)
Givefront | $2,000,000 | (Dec 23, 2025)